The European Medicines Agency (EMA) is working to secure additional doses of the COVID-19 vaccine developed by Pfizer and BioNTech with an aim to deliver 1.8 billion doses to Europe by the end of 2023 ...
The AstraZeneca jab is no longer recommended for people aged under 60 after new expert immunisation panel advice.
(Bloomberg) -- The US Department of Health and Human Services is ending contracts to develop vaccines using messenger RNA technology, another step in the agency’s changing practices toward vaccines ...
The mRNA vaccines authorised for emergency use do not use a live virus, while the Johnson & Johnson and Oxford/AstraZeneca jabs use a harmless adenovirus that has been modified to prevent replication.
The mRNA revolution didn’t end with COVID-19 – it’s only just beginning. With the MHRA’s latest guidance on personalized mRNA cancer vaccines and the world’s first RNA-based CRISPR therapy changing ...
To address waning immunity to COVID-19 vaccines and the emergence of immune-evasive SARS-CoV-2 variants, regular booster doses are widely recommended, especially for high-risk groups 1 However, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results